Strong deal flow brings in more than $1B in venture capital
A robust deal flow defined the first quarter of the year, which saw 60 global private biotech companies generate more than $1 billion. Not a bad haul and two and half times the amount generated in the same period last year from 45 deals.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter